Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 4 1

Status

Completed 56Terminated 10Withdrawn 8Unknown 4Recruiting 2Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4Observational 2

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Colorectal Neoplasms 3Recurrence 1Advanced Colorectal Cancer 1

Interventions

Cisplatin 504Cyclophosphamide 353Radiotherapy 349Carboplatin 347Capecitabine 328Oxaliplatin 319Paclitaxel 316Gemcitabine 315Docetaxel 308Fluorouracil 281apatinib 240Drug Therapy 239Bevacizumab 224camrelizumab 212Etoposide 199Irinotecan 176Doxorubicin 174Dexamethasone 159Leucovorin 158sintilimab 140Pemetrexed 136Cytarabine 136pembrolizumab 135anlotinib 135toripalimab 124S 1 (combination) 119Neoadjuvant Therapy 119Vincristine 118Rituximab 114Radiosurgery 113

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × Interventional × aflibercept × Clear all
NCT04810585 2021-03-23

Plasma Biomarker for Aflibercept in Advanced Colorectal Cancer

Yonsei University

Phase 4 Unknown
153 enrolled
Gastrointestinal

Recurrence, Colorectal Neoplasms

NCT04252456 2020-02-05

DISTINCTIVE

Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente

Phase NA Unknown
150 enrolled
Gastrointestinal

Advanced Colorectal Cancer

NCT02331927 2019-09-20

PERMAD

University of Ulm

Phase 2 Unknown
150 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT02624726 2019-02-22

MINOAS

Hellenic Oncology Research Group

Phase 2 Unknown
31 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡